Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants - Top-Institutions - MDSpire

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants

  • By

  • J R Passweg

  • H Baldomero

  • P Bader

  • C Bonini

  • S Cesaro

  • P Dreger

  • R F Duarte

  • C Dufour

  • J H F Falkenburg

  • D Farge-Bancel

  • A Gennery

  • N Kröger

  • F Lanza

  • A Nagler

  • A Sureda

  • M Mohty

  • February 2, 2015

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematopoietic Stem Cell Transplantation
    • Bone Marrow Transplantation
    • Hematology-Oncology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematopoietic Stem Cell Transplantation
    • Hematology
    • Oncology

  • #3

    European Society for Blood and Marrow Transplantation (EBMT) Coordinating Centers
    European Society for Blood and Marrow Transplantation (EBMT) Coordinating Centers

    Various (Europe-wide)

    Key Differentiators

    • Hematopoietic Stem Cell Transplantation
    • Transplant Registry Management
    • Clinical Research

  • #4

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematopoietic Stem Cell Transplantation
    • Hematology-Oncology
    • Bone Marrow Transplantation

  • #5

    University Hospital Heidelberg
    University Hospital Heidelberg

    Heidelberg

    Key Differentiators

    • Hematopoietic Stem Cell Transplantation
    • Immunology
    • Hematology

Original Source(s)

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants

  • by J R Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, R F Duarte, C Dufour, J H F Falkenburg, D Farge-Bancel, A Gennery, N Kröger, F Lanza, A Nagler, A Sureda, M Mohty

  • February 2, 2015

Related Content

The First NCI-Designated Comprehensive Cancer Center Using 3D Genomics Testing to Diagnose Lymphoma and Sarcoma—a True Game Changer

Diagnosing lymphoma and sarcoma can be extraordinarily complex, with more than 70 recognized subtypes of lymphoma and more than 100 distinct types of sarcoma. Many subtypes share similar features yet behave in dramatically different ways in standard testing, leaving oncologists with diagnostic quandaries and delays to treatment.

  • by

  • February 24, 2026

  • 4 min
CLINICOPATHOLOGICAL FEATURES OF ADULT LYMPHOBLASTIC LYMPHOMA: A RETROSPECTIVE MULTICENTER STUDY FROM TÜRKİYE

Mechanisms of first-line treatment resistance in diffuse large B-cell lymphoma